Proteoid biodynamers for safe mRNA transfection via pH-responsive nanorods enabling endosomal escape.

Biopolymer Gene delivery Nanorod Polymeric vector Stimuli-responsive Structure analysis mRNA delivery

Journal

Journal of controlled release : official journal of the Controlled Release Society
ISSN: 1873-4995
Titre abrégé: J Control Release
Pays: Netherlands
ID NLM: 8607908

Informations de publication

Date de publication:
01 2023
Historique:
received: 11 07 2022
revised: 05 12 2022
accepted: 08 12 2022
pubmed: 16 12 2022
medline: 3 2 2023
entrez: 15 12 2022
Statut: ppublish

Résumé

The recent success of mRNA vaccines using lipid-based vectors highlights the importance of strategies for nucleotide delivery under the pandemic situation. Although current mRNA delivery is focused on lipid-based vectors, still they need to be optimized for increasing stability, targeting, and efficiency, and for reducing toxicity. In this regard, other vector systems featuring smart strategies such as pH-responsive degradability and endosomal escape ability hold the potential to overcome the current limitations. Here, we report pH-responsive polymeric nanorods made of amino acid-derivatives connected by dynamic covalent bonds called proteoid-biodynamers, as mRNA vectors. They show excellent biocompatibility due to the biodegradation, and outstanding transfection. The biodynamers of Lys, His, and Arg or monomer mixtures thereof were shown to form nanocomplexes with mRNA. They outperformed conventional transfection agents three times regarding transfection efficacy in three human cell lines, with 82-98% transfection in living cells. Also, we confirmed that the biodynamers disrupted the endosomes up to 10-fold more in number than the conventional vectors. We discuss here their outstanding performance with a thorough analysis of their nanorod structure changes in endosomal microenvironments.

Identifiants

pubmed: 36521693
pii: S0168-3659(22)00833-1
doi: 10.1016/j.jconrel.2022.12.018
pii:
doi:

Substances chimiques

RNA, Messenger 0
Lipids 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

915-929

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Sangeun Lee (S)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany. Electronic address: sangeun.lee@uni-saarland.de.

Sarah Nasr (S)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany; Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt.

Sari Rasheed (S)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany.

Yun Liu (Y)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany.

Olga Hartwig (O)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.

Cansu Kaya (C)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany.

Annette Boese (A)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany.

Marcus Koch (M)

INM - Leibniz Institute for New Materials, Campus D2 2, 66123 Saarbrücken, Germany.

Jennifer Herrmann (J)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany.

Rolf Müller (R)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany; German Centre for Infection Research (DZIF), Braunschweig, Germany; Helmholtz International Lab - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany.

Brigitta Loretz (B)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany.

Eric Buhler (E)

Laboratoire Matière et Systèmes Complexes (MSC), UMR CNRS 7057, Université Paris Cité, Bâtiment Condorcet, 75205 Paris Cedex 13, France.

Anna K H Hirsch (AKH)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany; Helmholtz International Lab - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany. Electronic address: anna.hirsch@helmholtz-hips.de.

Claus-Michael Lehr (CM)

Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI), Campus E 8.1, 66123 Saarbrücken, Germany; Department of Pharmacy, Saarland University, 66123 Saarbrücken, Germany. Electronic address: claus-michael.lehr@helmholtz-hips.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH